ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Revenue

Alfresa Holdings Corporation (2784)

Market cap
¥417.9B
P/E ratio
18.8x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 20263,104,064+4.83%
Mar 31, 20252,961,051+3.59%
Mar 31, 20242,858,500+6.02%
Mar 31, 20232,696,069+4.27%
Mar 31, 20222,585,643-0.67%
Mar 31, 20212,603,169-3.53%
Mar 31, 20202,698,511+2.20%
Mar 31, 20192,640,511+1.44%
Mar 31, 20182,602,917+2.00%
Mar 31, 20172,551,801-0.95%
Mar 31, 20162,576,405+6.41%
Mar 31, 20152,421,162-3.33%
Mar 31, 20142,504,504+4.90%
Mar 31, 20132,387,511+2.33%
Mar 31, 20122,333,256

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat